Transitioning the paediatric IBD patient to adult care

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 17, Issue 2, 2003, Pages 197-212

  Désir, Barbara ^a,b   Seidman, Ernest G ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Crohn's disease; Inflammatory bowel disease; Management; Paediatric; Ulcerative colitis

Indexed keywords

ALENDRONIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; BUDESONIDE; CIPROFLOXACIN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PREDNISONE; SALAZOSULFAPYRIDINE;

ACNE; ADOLESCENT; ANAPHYLAXIS; ARTHRALGIA; AVASCULAR NECROSIS; BONE DISEASE; CHILD CARE; CLINICAL FEATURE; CLINICAL TRIAL; COLON CANCER; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG HYPERSENSITIVITY; EARLY DIAGNOSIS; ENDOCRINE DISEASE; ENTERITIS; FAMILY; FATIGUE; FEVER; GASTROENTEROLOGY; GROWTH RETARDATION; HEADACHE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFECTION; LEUKOPENIA; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER TOXICITY; MALNUTRITION; MEDICAL CARE; MEDICAL SPECIALIST; NAUSEA; NUTRITIONAL DISORDER; NUTRITIONAL SUPPORT; OSTEOPOROSIS; PANCREATITIS; PATIENT COMPLIANCE; PSYCHOSOCIAL CARE; RASH; REVIEW; SEXUAL DEVELOPMENT; STRIA; TEAMWORK; UPPER RESPIRATORY TRACT INFECTION; ADULT; AGE; CHILD HEALTH CARE; HEALTH SERVICE; ALLERGIC REACTION; CROHN DISEASE; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; MENTAL DISEASE; PHYSICAL EXAMINATION; ULCERATIVE COLITIS;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; ADULT; AGE FACTORS; GASTROENTEROLOGY; HEALTH SERVICES; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 0042411149     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6918(02)00145-2     Document Type: Review

References (84)

1. Collins S.M. Coexistence of inflammatory bowel disease and irritable bowel syndrome In Bayless T.M. & Hanauer S.B. (Eds.), Advanced Therapy of Inflammatory Bowel Disease 2001 87 BC Decker Hamilton, Ontario
2. Leichtner A. Jackson W. Grand R. Crohn's disease In Walker W. Hamilton J. & Walker-Smith J. (Eds.), Paediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management 1996 692 CV Mosby St Louis
3. Seidman E. LeLeiko N. Ament M. et al. Nutritional issues in pediatric inflammatory bowel disease Journal of Paediatric Gastroenterology and Nutrition 12 1991 424-438
4. Sarawicz C.M. Belic L. Rectal biopsy helps to distinguish acute self limited colitis from idiopathic inflammatory bowel disease Gastroenterology 86 1984 104
5. Thompson W.G. Longstreth G. Functional bowel disorders and functional abdominal pain In: Drossman D.A. (Ed.) Rome II-The Functional Gastrointestinal Disorders 2000 351 Degnon Ass VA
6. Joseph F. Rosenberg A.J. Identifying lactose malabsorption through breath hydrogen measurements Laboratory Medicine 17 1986 85
7. Olden K.W. Schuster M.M. Irritable bowel syndrome In Feldman M. Scharschmidt B.F. & Sleisenger M.H. (Eds.), Sleisenger and Fordtran's Gastrointestinal and Liver Disease 6th edn 1998 1536 Saunders Philadelphia, PA
8. Seidman E.G. Inflammatory bowel disease In Roy C. Silverman A. & Alagille D. (Eds.), Paediatric Clinical Gastroenterology 4th edn 1995 417 CV Mosby St Louis
9. Holmquist L. Ahren C. Fallstrom S.P. Relationship between results of laboratory tests and inflammatory activity assessed by colonoscopy in children and adolescents with ulcerative colitis and Crohn's colitis Journal of Paediatric Gastroenterology and Nutrition 9 1989 187-193
10. Beattie R.M. Walker-Smith J. Murch S.H. Indications for investigation of chronic gastrointestinal symptoms Archives of Disease in Childhood 73 1995 354-355
11. Hassal E. Barclay G.N. Ament M.E. Colonoscopy in childhood Paediatrics 73 1984 594-599
12. Seidman E.G. Role of endoscopy in pediatric inflammatory bowel disease Gastrointestinal Endoscopy Clinics of North America 11 2001 641-657
13. Seidman E.G. Gastrointestinal manifestations of primary immunodeficiency disorders In Walker W.A. et al. (Eds.), Paediatric Gastrointestinal Disease-Pathophysiology, Diagnosis, Management 3rd edn 2000 525 BC Decker Hamilton, Ontario
14. Dubinsky M.C. Ofman J.J. Urman M. et al. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease American Journal of Gastroenterology 96 2001 758-765
15. Ruemmele F.M. Targan S.R. Levy G. et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease Gastroenterology 115 1998 822-829
16. Quinton J.F. Sendid B. Reumaux D. et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) combined with anti-neutrophil antibodies (ANCA) differentiate Crohn's disease from ulcerative colitis Gastroenterology 112 1997 A1066 (abstract)
17. Spalinger J.H. Patriquin H. Miron M.-C. et al. Doppler sonography in pediatric Crohn's disease: vessel density in the diseased bowel reflects disease activity Radiology 217 2000 787-791
18. Charron M. Del Rosario F. Kocoshis S. Assessment of terminal ileal and colonic inflammation in Crohn's disease with 99m-Tc-WBC Acta Paediatrica 88 1999 193-198
19. Mack D. Young R. Kaufman S. et al. Methotrexate in patients with Crohn's disease after 6-mercaptopurine Journal of Paediatrics 132 1998 830-835
20. Leichtner A. Aminosalicylates for the treatment of inflammatory bowel disease Journal of Paediatric Gastroenterology and Nutrition 21 1995 245-252
21. Summers R.W. Surtz D.M. Sessions J.T. et al. National Cooperative Crohn's Disease Study: results of drug treatment Gastroenterology 77 1979 847-869
22. Malchow H. Ewe E.K. Brandis J.W. et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment Gastroenterology 86 1984 249-266
23. Sachar D.B. Budesonide for inflammatory bowel disease. Is it a magic bullet? New England Journal of Medicine 331 1994 873-874
24. Rutgeerts P. Lofberg R. Malchow H. et al. A comparison of budesonide with prednisolone for active Crohn's disease New England Journal of Medicine 331 1994 842-845
25. Brandt L.J. Bernstein C.H. Boley S.J. Frank M.S. Metronidazole therapy for perineal Crohn's disease: a follow-up study Gastroenterology 83 1982 383-387
26. Colombel J.F. Lemann M. Cassagnou M. et al. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease American Journal of Gastroenterology 94 1999 674-678
27. Steinhart A.H. Feagan B.G. Wong C.J. et al. Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial Gastroenterology 123 2002 33-40
28. Markowitz J. Rosa J. Grancher K. et al. Long term 6-mercaptopurine treatment in adolescents with Crohn's disease Gastroenterology 99 1990 1347-1355
29. Verhave M. Winter H.S. Grand R.J. Azathioprine in the treatment of children with inflammatory bowel disease Journal of Paediatrics 117 1990 809-814
30. Present D.H. Korelitz B.I. Wisch N. et al. Treatment of Crohn's disease with 6-mercaptopurine New England Journal of Medicine 302 1980 981-987
31. Bouhnik Y. Lemann M. Mary J.Y. et al. Long term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine Lancet 347 1996 215-219
32. Kirshner B.S. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease Gastroenterology 115 1998 813-820
33. Dubinsky M.C. Lamothe S. Yang H.Y. et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease Gastroenterology 118 2000 705-713
34. Cuffari C. Hunt S. Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease Gut 48 2001 642-646
35. Feagan B.G. Rochon J. Fedorak R. et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators New England Journal of Medicine 332 1995 292-297
36. Chong R.Y. Hanauer S.B. Cohen R.D. Efficacy of parenteral methotrexate in refractory Crohn's disease Alimentary Pharmacology and Therapeutics 15 2001 35-44
37. Feagan B.G. Fedorak R.N. Irvine E.J. et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators New England Journal of Medicine 342 2000 1627-1632
38. Zenjari T. Lemman M. Mesnard B. Methotrexate in Crohn's disease: long-term efficacy and toxicity Gastroenterology 110 1996 794 (abstract)
39. Targan S.R. Hanauer S.B. van Deventer S.J. et al. A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor-alpha for Crohn's disease. Crohn's Disease cA2 Study Group New England Journal of Medicine 337 1997 1029-1035
40. Present D.H. Rutgeerts P. Targan S. et al. Infliximab for the treatment of fistulas in patients with Crohn's disease New England Journal of Medicine 340 1999 1398-1405
41. Hyams J.S. Use of infliximab in the treatment of Crohn's disease in children and adolescents Journal of Pediatric Gastroenterology and Nutrition 33 2001 S36-S39
42. Serrano M.S. Schmidt-Sommerfeld E. Kilbaugh T.J. et al. Use of infliximab in pediatric patients with inflammatory bowel disease Annals of Pharmacotherapy 35 2001 823-828
43. Blam M.E. Stein R.B. Lichtenstein G.R. Integrating anti-TNF therapy in inflammatory bowel disease: current and future perspectives American Journal of Gastroenterology 96 2001 1977-1997
44. Hanauer S.B. Feagan B.G. Lichtenstein G.R. et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial Lancet 359 2002 1541-1549 (In process citation)
45. Seidman E.G. Weber A.M. Morin C.L. Roy C.C. Inflammatory bowel disease in childhood In Freeman H.J. (Ed.), Inflammatory Bowel Disease Vol. 2 1989 217-247 CRC press Boca Raton, FL
46. Griffiths A.M. Ohlsson A. Sherman P.M. Sutherland L.R. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease Gastroenterology 108 1995 1056-1067
47. Fernandez-Banares F. Cabre E. Esteve-Copmas M. Gassull M.A. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease: a meta-analysis of the randomized clinical trials Journal of Parenteral and Enteral Nutrition 19 1995 356-364
48. Han P.D. Burk A. Baldassano R.N. et al. Nutrition and inflammatory bowel disease Gastroenterology Clinics of North America 28 1999 423-443
49. Belli D. Seidman E.G. Bouthillier L. et al. Chronic intermittent elemental diet improves growth failure in Crohn's disease Gastroenterology 94 1988 603-610
50. Seidman E.G. Nutritional therapy for Crohn's disease: lessons from the Ste-Justine Hospital experience Inflammatory Bowel Disease 3 1997 49-53
51. Seidman E.G. Bagnell D. Griffiths A.M. et al. Canadian Collaborative Paediatric Crohn's Disease Study: growth failure and nutritional deficiencies in pediatric patients with active Crohn's disease Gastroenterology 100 1991 A249 (abstract)
52. Blair G.K. Yaman M. Wesson D.E. Preoperative home enteral nutrition in children with inflammatory bowel disease Journal of Paediatric Surgery 21 1986 769-771
53. Teahon K. Smethurst P. Pearson M. et al. The effect of elemental diet on permeability and inflammation in Crohn's disease Gastroenterology 101 1991 84-89
54. Seidman E. Gastrointestinal benefits of enteral feeds In Baker S. Baker S. & Davis A. (Eds.), Paediatric Enteral Nutrition 1994 46-66 Chapman and Hall New York
55. Nelson L.M. Elemental diet composition and the structure and function of rat small intestine: comparison of the effects of two diets on morphology and in vivo absorption of water Journal of Parenteral and Enteral Nutrition 5 1981 204-206
56. Lorenz-Meyer H. Bauer P. Nicolay C. et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease Scandinavian Journal of Gastroenterology 31 1996 778-785
57. Vilaseca J. Salas A. Guarner F. et al. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis Gut 13 1990 534-539
58. Ruemmele F.M. Roy C.C. Levy E. Seidman E.G. Nutrition as primary therapy in pediatric Crohn's disease: fact or fantasy? Journal of Pediatrics 136 2000 285-291
59. Sands B.E. Medical therapy of steroid-resistant Crohn's disease Canadian Journal of Gastroenterology 14 2000 33C-37C (supplement C)
60. Hyams J.S. Carey D.E. Corticosteroids and growth Journal of Paediatrics 113 1988 249-255
61. Markowitz J. Grancher K. Rosa J. et al. Growth failure in pediatric chronic inflammatory bowel disease Journal of Paediatric Gastroenterology and Nutrition 18 1994 165-173
62. Motil K.J. Grand R.J. Davis-Kraft L. et al. Growth failure in children with inflammatory bowel disease: a prospective study Gastroenterology 105 1993 681-691
63. Compston J.E. Review article: osteoporosis, corticosteroids and inflammatory bowel disease Alimentary Pharmacology and Therapeutics 9 1995 237-250
64. Silvennoinen J.A. Karttunen T.J. Niemela S.E. et al. A contolled study of bone mineral density in patients with inflammatory bowel disease Gut 37 1995 71-76
65. Bernstein C.N. Blanchard J.F. Leslie W. et al. The incidence of fracture among patients with inflammatory bowel disease Annals of Internal Medicine 133 2000 795-799
66. Scott E.M. Gaywoood I. Scott B.B. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease Gut 46 2000 1-8 (supplement 1)
67. Herzog D. Bishop N. Glorieux F. et al. Interpretation of bone mineral density values in pediatric Crohn's disease Inflammatory Bowel Disease 4 1998 261-267
68. Schoon E.J. Blok B.M. Geerling B.J. et al. Bone mineral density in patients with recently diagnosed inflammatory bowel disease Gastroenterology 119 2000 1203-1208
69. Gennari C. Civitelli R. Glucocorticoid-induced osteoporosis Clinics in Rheumatic Diseases 12 1986 637-654
70. Boot A.M. Bouquet J. Krenning E.P. et al. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease Gut 42 1998 188-194
71. Saag K.G. Emkey R. Schnitzer T.J. et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced Osteoporosis Intervention Study Group New England Journal of Medicine 339 1998 292-299
72. Levin B. Inflammatory bowel disease and colon cancer Cancer 70 1992 1313
73. Ekbom A. Helmick C. Zack M. Adami H.O. Increased risk of large bowel cancer in Crohn's disease with colonic involvement Lancet 336 1990 357
74. Choi P.M. Zelig M.P. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention Gut 35 1994 950-954
75. Greenstein A.J. Sachar D.B. Smith H. et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk Gastroenterology 77 1979 290-294
76. Shetty K. Rybicki L. Brzezinski A. et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis American Journal of Gastroenterology 94 1999 1643-1649
77. Ekbom A. Helmick C. Zack M. Adami H.O. Ulcerative colitis and colorectal cancer. A population-based study New England Journal of Medicine 323 1990 1228-1233
78. Kornbluth A. Sachar D.B. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee American Journal of Gastroenterology 92 1997 204-211
79. Winawer SJ Fletcher RH Bond JH et al. American Gastroenterological Association Medical Position Statement: Colorectal Cancer Screening AGA, 1996.
80. Anonymous Colorectal cancer screening. ACS guidelines CA: A Cancer Journal for Clinicians 49 1999 4 (News)
81. Kyngäs H. Kroll T. Duffy M.E. Compliance in adolescents with chronic disease: a review Journal of Adolescent Health 26 2000 379-388
82. Burke P. Meyer V. Kocoshis S. et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis Journal of the American Academy of Child and Adolescent Psychiatry 28 1989 948-951
83. Engstrom I. Inflammatory bowel disease in children and adolescents: mental health and family functioning Journal of Pediatric Gastroenterology and Nutrition 28 1999 S28-S33
84. Moody G. Eaden J.A. Mayberry J.F. Social implications of childhood Crohn's disease Journal of Pediatric Gastroenterology and Nutrition 28 1999 S43-S45